Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline in Bone and Joint Infections
NCT02005068Phase 4Withdrawn
- Start
- Apr 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftaroline fosamil in osteomyelitis (OM), prosthetic joint infection (PJI). Planned start Apr 2013; status: withdrawn.
02
Drugs
ceftaroline fosamil
03
Conditions
osteomyelitis (OM)prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT02005068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005068.